Traws Pharma, Inc. Common Stock (TRAW) is a publicly traded Healthcare sector company. As of May 21, 2026, TRAW trades at $1.64 with a market cap of $26.67M and a P/E ratio of -0.94. TRAW moved +3.14% today. Year to date, TRAW is +25.58%; over the trailing twelve months it is +29.60%. Its 52-week range spans $0.97 to $19.44. Rallies surfaces TRAW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Traws Pharma, Inc. Common Stock (TRAW) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TRAW moved +3.14% today.
| Metric | Value |
|---|---|
| Price | $1.64 |
| Market Cap | $26.67M |
| P/E Ratio | -0.94 |
| EPS | $-1.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.44 |
| 52-Week Low | $0.97 |
| Volume | 933.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.73M |
| Net Income | $-19.43M |
| Gross Margin | 0.00% |
TRAW analyst coverage data. Average price target: $0.00.